Disease/Infection News

RSS

SARS-CoV-2 monitoring could be improved with use of bacterial metatranscriptomes in wastewater

In a recent research report from the United States, currently available on bioRxiv* preprint server, scientists have shown that bacterial taxonomic and functional profiles can discriminate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) status even without directly detecting viral transcripts – opening the door for entirely novel approaches in wastewater-based epidemiology.

27 Feb 2022

No seroprevalence observed against SARS-CoV-2 in wild ruminants in Germany

A team of scientists from Germany has recently conducted a serological screening on wild animals to assess seroprevalence against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other pathogenic viruses related to domestic ruminants.

27 Feb 2022

Study determines effectiveness of COVID-19 vaccination against Omicron variant in high-risk indoor settings

A new study estimates vaccine effectiveness against SARS-CoV-2 Omicron variant in indoor entertainment settings in Australia.

27 Feb 2022

Will Omicron BA.2 become the next dominant variant?

A new study presents a comprehensive analysis of the potential of both Omicron BA.2 and BA.3 to become the next dominant circulating SARS-CoV-2 strain.

27 Feb 2022

Emergence of SARS-CoV-2 Omicron likely due to immune selective pressure

A new study discusses the emergence of new variants of SARS-CoV-2 that can escape antibody-mediated neutralization, as opposed to other Sarbecoviruses.

27 Feb 2022

Altered microbiomes in SARS-CoV-2 infection pose threat of antibiotic resistance

A new study discusses changes in the microbiota of various parts of the body with SARS-CoV-2 infection.

27 Feb 2022

Study finds waning protection of COVID-19 vaccines after six months

A study released in The Lancet Respiratory Medicine by Providence, one of the largest health systems in the United States, confirms the overall effectiveness of vaccines in preventing severe infection resulting in hospitalization from Covid-19, but also shows a substantial decline in protection after six months.

27 Feb 2022

The epidemiology of COVID-19 in Africa

A new study uses the Africa CDC generic protocol for obtaining COVID-19 seroprevalence data to understand the spread and epidemiology of SARS-CoV-2.

27 Feb 2022

A promising new vaccine for SARS-CoV-2 and influenza

Researchers create a vaccine candidate that could protect against both SARS-CoV-2 and IAVs.

27 Feb 2022

ECMO shortage linked to the death of young, healthy COVID-19 patients

Nearly 90 percent of COVID-19 patients who qualified for, but did not receive, ECMO (extracorporeal membrane oxygenation) due to a shortage of resources during the height of the pandemic died in the hospital, despite being young with few other health issues, according to a study published in the American Journal of Respiratory and Critical Care Medicine.

25 Feb 2022

Mosquito net use in early childhood increases chances of survival into adulthood

Children who sleep more often under insecticide-treated bed nets have more than 40 per cent higher likelihood of surviving into adulthood than their counterparts who use bed nets less often, a study suggests.

25 Feb 2022

Examining a case study of COVID-19 response and vaccine hesitancy in South Africa

Researchers proposed an approach that assesses community-based case studies to examine vaccine hesitancy and the response to COVID-19-related public health behaviors in South Africa.

25 Feb 2022

Clinical severity of patients hospitalized with SARS-CoV-2 infection during the Omicron wave in South Africa

The study findings show that the Omicron-dominant fourth wave of COVID-19 reversed the rising SARS-CoV-2 cases and hospitalization trend seen in the previous three waves in South Africa.

25 Feb 2022

Overview of syphilis, gonorrhea and chlamydia cases in non-EU/EEA countries of the WHO's European Region

In their article published in Eurosurveillance, Bozicevic et al. analyzed data on reported cases of syphilis, gonorrhea and chlamydia for the period 2015 to 2019 from 18 non-EU/EEA countries of the World Health Organization's European Region.

25 Feb 2022

Outcomes of SARS-Cov-2 infection in patients undergoing active anti-cancer treatment

Researchers demonstrated that irrespective of the type of ACT, SARS-CoV-2 infection rates in patients receiving ACT remained comparable to the general population.

25 Feb 2022

Protective immunity signatures provided by convalescent plasma for the development of COVID-19 antibody therapeutics

Researchers conducted a comprehensive and systematic analysis of functional SARS-CoV-2 antibody profiles in a controlled randomized trial of severe COVID-19 hospitalized individuals treated with COVID-19 CCP.

25 Feb 2022

Study suggests history of childhood traumas may increase the risk of long COVID

In a new study, researchers found childhood trauma to be a risk factor for post-coronavirus disease.

25 Feb 2022

Rapid evidence summary on SARS-CoV-2 surface survival and efficacy of ozone machines against SARS-CoV-2

Researchers of WC19EC conducted a rapid systematic literature review to assess the safety, effectiveness, and efficacy of SARS-CoV-2 disinfection methods, including the ozone devices, in schools.

25 Feb 2022

mRNA vaccines found to be highly effective against COVID-19 infections before the emergence of SARS-CoV-2 Delta variant

Researchers evaluated the efficacy of SARS-CoV-2 vaccines made by Pfizer, Jansen, and Moderna against symptomatic and asymptomatic COVID-19 cases.

25 Feb 2022

Severe COVID-19 outcomes in breakthrough infections in patients being treated with B cell depleting therapy

Scientists evaluated the incidence and severity of breakthrough SARS-CoV-2 infections among individuals with immune-mediated inflammatory diseases undergoing B cell depleting therapy.

25 Feb 2022

Disease/Infection News

SARS-CoV-2 monitoring could be improved with use of bacterial metatranscriptomes in wastewater

No seroprevalence observed against SARS-CoV-2 in wild ruminants in Germany

Study determines effectiveness of COVID-19 vaccination against Omicron variant in high-risk indoor settings

Will Omicron BA.2 become the next dominant variant?

Emergence of SARS-CoV-2 Omicron likely due to immune selective pressure

Altered microbiomes in SARS-CoV-2 infection pose threat of antibiotic resistance

Study finds waning protection of COVID-19 vaccines after six months

The epidemiology of COVID-19 in Africa

A promising new vaccine for SARS-CoV-2 and influenza

ECMO shortage linked to the death of young, healthy COVID-19 patients

Mosquito net use in early childhood increases chances of survival into adulthood

Examining a case study of COVID-19 response and vaccine hesitancy in South Africa

Clinical severity of patients hospitalized with SARS-CoV-2 infection during the Omicron wave in South Africa

Overview of syphilis, gonorrhea and chlamydia cases in non-EU/EEA countries of the WHO's European Region

Outcomes of SARS-Cov-2 infection in patients undergoing active anti-cancer treatment

Protective immunity signatures provided by convalescent plasma for the development of COVID-19 antibody therapeutics

Study suggests history of childhood traumas may increase the risk of long COVID

Rapid evidence summary on SARS-CoV-2 surface survival and efficacy of ozone machines against SARS-CoV-2

mRNA vaccines found to be highly effective against COVID-19 infections before the emergence of SARS-CoV-2 Delta variant

Severe COVID-19 outcomes in breakthrough infections in patients being treated with B cell depleting therapy

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News